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Abstract
G row th horm one (G H ) is resp onsib le fo r d iverse physiological
processes. In order to carry out these processes, it uses several signaling
pathw ays involving dim erization of GHRs, form ation of GHR-JAK2 com plex,
and activation of the com plex by phosphorylation. One of the pathw ays it
uses is PKC signaling pathw ay. There is evidence indicating PLC -gam m al is
involved in this pathway.

w
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Introduction
G row th horm one (G H ), an anabolic horm one, has been linked to
diverse physiological processes. Major roles in which GH is known for are its
involvem ent in body grow th and m uscle developm ent. A lso, GH has been
found to play a role in metabolic functions such as lipid oxidation, amino add
uptake, and protein sythesis (A rgesinger & C arter-Su, 1996). Due to GH
diverse roles, it was suspected that GH uses a number of signaling pathways.
One of the GH signaling pathw ays for w hich evidence is startin g to
accum ulate is PLC-gam m a. In this paper, structures and functions of GH and
its receptor GHR will be review ed. Also, signaling pathw ays involving JAK2
will be addressed. Furtherm ore, the background inform ation of PLC and its
possible involvem ent in GH signaling pathw ay will be considered.

G row th Horm one
Background inform ation regarding grow th horm one:
G row th horm one (GH) is m ade up of a fam ily of proteins and is
heterogenic (Beattie & Flint, 1993). A ccording to B eattie and Flint (1993),
heterogeneity m ay occur at genom ic level, causing varitaions in term s of size,
glycosylation, phosphorylation, and acetylation. A lthough sizes of GH vary,
22 kDa is considered the common form. Also, GH has been found to form a 4alpha helix (Beattie & Flint, 1993). GH is released from the pituitary gland in to
circulation, to be detected by target organs. One of the main target organs for
GH is the liver. In order for GH to take its effects, it m ust bind to receptors on
plasm a membrane of cells in target organs (Campbell, 1997; Postel-Vinary &
Finidori, 1995).
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Growth horm one receptor:

Two types of receptors in cell plasm a m em brane has been found to
bind to hum an grow th horm one (hGH): grow th horm one recep tor (GHR)
and prolactin receptors. In this paper, we will focus m ainly on GHR. GHRs
have been show n to be a m em ber of cytok in e/h em atop oietin receptor
superfam ily (B azan, 1990). This superfam ily also includes p ro lactin ,
erythropoietin and som e grow th-factor related receptors (Cam pbell, 1997).
One characteristic feature of this family is that they are able to produce a wide
varitey of effects on a large numbers of tissues and cells (Argetsinger & C arterSu, 1996).
GHRs are m ade up of 620 amino adds. Also, GHRs are glycoslyated and
ubiquitin-conjugated, although their functions are still unknown (Beattie &
Flint, 1993). GHRs, which are single-pass receptors, generally have three parts:
extracellular protein domain, a transm em brane dom ain, and an intracellular
domain (Argetsinger & Carter-Su, 1996; Kossiakoff, 1995).
The extracellular dom ain of GHR, w hich is also know n as grow th
horm one binding protein (GHBP), consists of 28 kDa of proteins or 246 amino
add s. It contains ligand-binding portion WXSWS (deVos et al., 1992) . In
hum ans, extracellular dom ain includes tw o dom ains w hich are each m ade
up of antiparallel seven b eta strands (K ossiakoff, 1995; Postel-V inay &
Findori, 1995). The N -term inal portion of the dom ain consists of six cysteine
residues, w hich join together to form three disulfide bonds (Postel-Vinay &
Findori, 1995). It is suspected that GHBP m ight be involved in horm one
clearance regulation (Kossiakoff, 1995; VanderKuur et al. 1994). A lso, GHBP
on its ow n has been identified as a soluble variant of GHR (Beattie & Flint,
1993; Postel-Vinay & Findori, 1995). This variant has been found in blood
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serum and biological fluids (Baumann et al. 1986; Postel-Vinay et al. 1991). It
is believed that this variant GHBP is derived from proteolytic cleavage of the
full-length m em brane receptor (Leung et al. 1987; Postel-Vinay & Findori,
1995).
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Figure 1. Schem atic depiction of GHR and GHBP. (Postel-Vinay &
Finidori, 1996)
Transmembrane portion of the receptor consists of 24 amino ad d . Little
inform ation was available on significance or specific function of this portion.
It is believed that transmembrane is a passive com ponent of signaling process
(Penta & Carpenter, 1997).
Intracellular dom ain of the recep tor plays a cru rial role in cellular
signal transduction (e.g. Argetsinger & Carter-Su, 1996; Baum an et al, 1994). It
contains of two m otifs: Box 1 and Box 2. Box 1 is proline-rich and it is found
d oser to the membrane. It cosists of eight am ino add s (hydrophobic residuesX -X -X -A l-P-X -P ) (Bazan, 1989; Carter-Su et al., 1996; Cosm an et al, 1990). In
mammals, the sequece is ILPPVPVP. Box 1 is commonly found in

cytokeine/hem atopoietin superfam ily. Box 2 consists of hydrophobic amino
ad d s and charged amino ad d s. Box 2 is found approxim ately 30 amino adds
carboxy terminal to Box 1 (Carter-Su et al., 1996).

Binding of GH and receptor dim erization;
M any stud ies have rep orted th at intial stage of GH signaling is
characterized by binding of GH to two GHRs (Argetsigner & Carter-Su, 1996).
It has been found that GH contains two receptor sites, site 1 and site, 2 which
allow them to bind to two receptors (Smit & Carter-Su, 1996). It was observed
that hydrophobic portion of GHR, w hich is located on the inside, is m ore
critical in binding (W ells, 1996). Reaction which followed betw een the tw o
receptor molecules account for the form ation of hom odim er com plex (de Vos
et al., 1992). It appears that GH-GHR binding occurs sequentially w ith site 1
binding to receptor prior to site 2 binding (Wells, 1996). It has been reported
that disturbance in one of the binding sites causes cessation of GH action (Fuh
et al., 1992).
Also, in binding, extarcellular dom ain of receptors can accom adate for
a cavity in Site 1 of GH (K ossiakoff, 1995). It has been proposed th at
dim erization of GHR and associated conform ational changes are necessary for
GH action (Carter-Su et al., 1996) and for cellular proliferation (Argetsinger &
Carter-Su, 1996).

JAK2 tyrosine kinase activation by GH:
GHR dim erization is rapidly followed by binding of JAK2 to GHR and
its activation. JAK2, which is a m ember of Janus family, is a tyrosine kinase.
A t present, Janus family includes JAK1, JAK2, JAK3 and tyk2 (Argetsinger &

Carter-Su, 1996; Firm bach-Kraft et al., 1990; H arpur et al., 1992). It has been
observed that even though JAK2 is the m ost crucial one to be activated by
GHR dim erization, JAK1 and JAK3 m ay also play a lesser role in m oderating
GH effects (Argetsinger & Carter-Su, 1996; Carter-Su, 1996).
Furtherm ore, the significances of JAK kinases are not lim ited to GH.
JAK kinases are activated by m ost m em bers of cytok in e/h em atop oeitin
receptor family m embers w ith differential preferences (Argetsinger & C arterSu, 1996; C arter-Su et al, 1996). V ariations in activation preferences and
ch aracteristics acco u n t for signaling sp ecificity seen am ong receptors
(Argetsinger & Carter-Su, 1996).
This specificity seen am ong signaling recep tors is a crucial link in
understanding GH signaling. Follow ing form ation of GHR-GHR com plex,
JAK2 affinity for GHR increases (Argetsinger et al., 1993; Argetsinger & C arterSu, 1996). Studies have also show n that m utation in Box 1 of GHR leads to
disruptions in GH action (A rgetsinger & C arter-Su, 1996). M oreover, Box 1
appears to be essetial for GHR-JAK2 com plex form ation and for eventual
tyrosyl phosphorylation of JAK2 (Argetsinger & Carter-Su, 1996; Frank et al.,
1994). Thus, A rgetsinger & Carter-Su (1996) had suggested that JAK2 binds
directly to Box 1 of GHR. This binding of tw o JAK2 molecules to tw o receptors
lead to tyrosyl phosphorylation of kinase dom ain of the JAK2 m olecules
(Argetsinger & Carter-Su, 1996). This activates JAK2.
Im m ediately following JAK2 activation, cytoplasm ic dom ain of GHR
appears to be phosphorylated by JAK2 (A rgetsinger et al, 1993). It w as
suggested that depending on the type of tyrosine phosphorylated on JAK2,
JAK2 is able to signal multiple signaling pathways. This suggestion is

supported byt the findings of a number of tyrosines in JAK2 (e.g. 48 tyrosines
in m urine JAK2) (Argetsinger & Carter-Su, 1996).
T herefore, in sum m ary, form ation of GHR dim erization m akes it
possible for two JAK2 m olecules to bind w ith tw o GHRs. This in turn causes
tyrosyl ph osphorylation of kinase dom ain of JA K 2, lead ing to JAK2
activation. It has been proposed that the crucial role of GHR dim erization is
to activate JAK2 and in later signaling events, JAK2 m ay be m ore essential
than GHR (Carter-Su et al., 1996).

The role of SH2 in GH signaling:
T yrosyl phosphorylation has been associated w ith binding of Src
homology 2 (SH2) of specific proteins to JAK2. This binding appears to have
m odulatory effects on signaling processes (Pawson & Schlessinger, 1994). It is
believed that these proteins are also phosphorylated by JAK2 (Carter-Su et al.,
1996). Also, the ability to bind to SH2 of specific proteins im plicates that there
exits specific signaling pathways (Pawson & Schlessinger, 1993). These specific
signaling pathways are believed to involve tyrosine kinases and phosphatases
(C arter-Su et al., 1996). Some of the signaling pathw ays that have been
obsesrved are m itogen-activated protein (M AP) kinases, insulin recep tor
substrates 1 and 2, phosphatidylinositol 3' kinase, and protein kinase C (PKC).
H ere, a brief overview of these pathways will be given.

Involvem ent of GH in MAP kinases signaling pathw ay:
M AP kinases, w hich are im portan t for regulation of grow th and
differentiation, necessitate phosphorylation by tyrosine and threonine to be
activated (Argetsinger & Carter-Su, 1996; Cobb & Goldsmith, 1995). They have
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been found to be activated by GH and a num ber of

tyrosine kinases

(Anderson, 1992; Carter-Su et al., 1996; Campbell et al., 1992). Two types of
MAP kinases that were found to be activated by GH are ERK1 and ERK 2.
One of the pathw ays in w hich GH activates M AP kinases involves
SHC, Grb2, son-of-sevenless (Sos), ras, raf, and MEK (Crews & Erickson, 1993).
One experim ent using 3T3-F442A fibroblasts has shown that GH is in volved
in tyrosyl phosphorylation of the 46-, 52-, and 66- kDa SHC proteins (CarterSu et al., 1996). This result and other experim ental evidences indicate that GH
prom otes association of SH 2 dom ain of SHC proteins w ith JAK2-GH R
com plexes (Argetsinger & Carter-Su, 1996; Carter-Su et al., 1996). It is assumed
that JAK2 phosphorylates SHC after binding (Argetsinger & Carter-Su, 1996).
Phosphorylation of SHC m akes attachm ent of Grb2 possible (A rgetsinger &
Carter-Su, 1996). Even though detail m echanism s involving the rest of the
w

signaling m olecules (Sos, ras, raf, and MEK) rem ain to be uncovered, it is
suspected that procurem ent of SHC and Grb2 are inital stages of ERKs 1 and 2

Figure2: Summ ary of the pathw asys (Carter-Su et al., 1996)

IRS-1, IRS-2, PI 3' Kinases and GH:
It has been observed that if cells are deprived of GH, they start to show
signs of insulin-like effects (Davidson, 1987). Therefore, it w as suspected that
GH and insulin have som e signaling pathw ays in com m on (A rgetsinger &
Carter-Su, 1996). However, the mechanism is expected to differ in som e ways.
One w ay in which GH m echansim m ay work is by utiliztion of JAK2 as an
interm ediary in assocation w ith GHR-JAK2 com plex (A rgetsinger & C arterSu, 1996). IRS-1 and ERS-2 are thought to be the substrates involved (W hite,
1996). This interaction provides binding site for PI 3’ kinase (Argetsinger et al.,
1995, Argetsinger & Carter-Su, 1996). It is believed that PI 3' kinase prom otes
insulin-like effects of GH.

STATs and GH:
It has been observed th at GH can have im pacts at genom ic level,
regarding grow th and m etabolism (Smit et al., 1996). One way of achieving
this is by activating Stat (signal transducers and activators of transcription)
proteins. Stat family of proteins have been recognized as gene transcription
factors. Stat 1, Stat 3, and Stat 5 appears to be significant factors in gene
regulation while Stat 4 appears to play a lesser role. Depending on the type of
cell, one of these four Stat proteins will be activated (Argetsinger & Carter-Su,
1996).
Studies have shown that activation of Stat by GH requires JAK2 (Han et
al, 1996). It appears that JAK2 activation causes recruitm ent of specific Stat
proteins (Smit et al., 1996). A fter binding of SHC dom ain of Stat protein to
G H R-JA K 2

com p lex, S tat

is

p h o sp h o ry lated

by

JA K 2.

Fo llo w in g

phosphorylation, Stat protein associates w ith other Stat proteins to form

hom odim ers and h eterd im ers. They then d etach ed from G H R-JAK2
com plex. A t this tim e, Stat protein can translocate to the nucleus, to govern
transcriptional processes of specific genes (Smit et al., 1996).

PKC and GH:
Protein kinase C (PKC) is a m ember of serine / threonine kinase family,
which has been a known protein phosphorylater and activator. The roles for
w hich PKCs have been associated are cellular grow th, m etabolism and
differentiation (Argetsinger & Carter-Su, 1996; Dekker & Parker, 1994; Hug &
Sarre, 1993) So far, 12 PKC isoforms has been identified.
Also, studies have shown that some of GH regulated processes such as
lipogenesis can be inhibited by reduction in PKC (A rgetsinger & C arter-Su,
1996; Gronowski et al., 1995). T herefore, it w as suspected th at GH m ay
m oderate these some processes by PKC activation (A rgetsigner & C arter-Su,
1996). Perhaps due to existence of isoform s, a num ber of signaling pathw ays
have been seen in GH activation of PKC. Some of the possible prom oters of
PKC activ ation are IRS-1, IRS-2, PI 3' kinase, phospholipase D and
phosphatidylcholine (A rgetsinger & C arter-Su, 1996; C arter-Su et al., 1996).
H ere, how ever, we will focus on possible involvem ent of PLC-gam m a, which
has only recently becam e a candidate for PKC activation prom oter.

Phospholipase C
Before considering PLC-gam m a specifically, we will briefly discuss its
b road er category, phospolipase C. It has been found th at activ ation of
phospholipase C can be achieved via phosphorylation of tyrosine kinases by
horm ones, including GH (Ji et al., 1997). A known function of activated
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phospholipase C (PLC) is to produce sencond m essengers, diacylglycerol
(DAG) and Ins 1, 4, 5-P3 (IPs), by hydrolyzing PI 4,5 P2. Release of DAG
activates the PKC pathw ay while IP3 acts on m em brane of endoplasm ic
reticulum to release Ca 2+ (Kam at & C arpenter, 1997). Since PLC substrate is
located in m em brane, PLC m ust in teract w ith m em brane during substrateenzyme reaction (Singer et aL, 1997).

W

Figure 3: Summary of PLC reaction (Singer et al., 1997)
C urrently, ten isozym es of PLC have been recognized and they h ave
been categorized into three types: PLC-beta, PLC-gam m a and PLC-delta. They
are all polypeptides (Rhee & Bae, 1997). Structurally, all PLC isoforms contain
X and Y regions, which are considered catatlytic core of the PLC molecule (Ji et
al., 1997; Singer et al., 1997). X region contains approxim ately 170 residues
while Y region contains approxim ately 260 residues. These X and Y regions
tightly bind together to form a

strucutre known as TIM barrel structure

w hich has an active site at C-term inus (Kam at & C arpenter, 1997). In PLCgam m a form s, X and Y regions are separated by approxim ately 400 amino
adds (Rhee & Bae, 1997).
In addition to X and Y regions, m ost PLC isozym es include a N terminal pleckstrin homolgy (PH) domain, and a C2 homology domain
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(Singer et al., 1997). Although exact role of PH is unclear, it has been seen in
association with PIP2 . The C2 domain, on the other hand, is necessary for Ca2f
of the enzyme (Singer et al., 1997). PLC-delta isoform, which weighs 85 kDa, is
seen as the most basic form of PLC while PLC-beta and PLC-gamma contain
additional structures to promote regulatory properties (Singer et al., 1997). It is
suggested that PLC-beta and PLC-gamma arose from PLC-delta (Rhee & Bae,
1997). PLC-beta weighs approximately 150 kDa and is made up of four genes
(Kamat & Carpenter, 1997). It is suspected that activity of PLC-beta is regulated
by heterotrimers of G proteins (Lee & Rhee, 1995; Katan, 1996).
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Figure 4: Types of PLCs (Kamat & Carpenter, 1997)
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PLC-Gam ma:
The m ost distinguishing feautre of PLC-gam m a is that it contains two
SH2 regions (N-SH2 and C-SH2) and one SH3 region. Although it is a notable
feature for a PLC, it is com m only seen in signaling pathw ays involving
tyrosine kinases (Cohen et al., 1995; Kam at & Carpenter, 1997; Pawson, 1995).
These regions m ay not be crucial in PLC -gam m al catalytic activity but they
m ay have m odulatory effects (Penta & Carpenter, 1997).
So far, two types of PLC-gam m a have been identified: PLC-gam m al and
PLC -gam m a2. Genes for PL C -gam m al and PL C -gam m a2 are found on
chrom osom es 20 and 16 in hum ans, and chrom osom es 2 and 8 in m ice
(Argeson et al., 1995; Hernandez et al., 1994; Kam at & Carpenter, 1997; Nelson
et al., 1992). They weigh approxim ately 145 kDa. O ut of the tw o form s, PLCgam m al has larger range of target areas while effects of PLC-gam m a2 are
lim ited to spleen and thym us (Em ori et al., 1989). It is believed that PLCgam m al plays an interm ediary role in GH-dependent PKC signalling pathway
and is responsible for control of intracellular Ca 2+ level.
One structural feature that allows PLC -gam m al to play its roles is SH
region in betw een X and Y regions (K am at & C arp enter, 1997). A fter
form ation of GH-induced GHR-JAK2 com plex, this SH2 region is needed to
interact w ith binding sites located on the receptors (Penta & Carpenter, 1997;
Singer et al., 1997). It has been proposed that this high affinity binding m ay
lead to conform ational changes and eventually result in phosphorylation
(Penta & Carpenter, 1997).
One conform ational change that has been suggested is that SH region
would create a extended loop, starting from the X and Y regions (Kam at &
Carpenter, 1997). In this model, there are two phosphorylation sites in this

loop: site Tyr 771 and site Tyr 783. There is also one m ore site, T yrl254, which
is further rem oved from the loop. Tyr 783 is the m ost critical site during
phosphorylation while the other two sites serve to ensure m axim um activity
(Kam at & Carpenter, 1997). Some studies have show n that Tyr 771 is not
necessary (Kim et al., 1991). During phosphorylation, SH2 regions can be seen
playing a m odulatory role.
Two changes have been observed during this phosphorylation period.
One is that there is a difference in Ks and Km (W ahl et al., 1992). A nother
change that has been seen is an increaesd in H2Q2 level, w hich m ay serve as
intracellular m essenger (Bae et al., 1997; Rhee & Bae, 1997).
A fter phosph orylation, P L C -gam m al is activ ated and it rapidly
detaches from the com plex to attaches itself to plasm a m em brane (Kam at &
Carpenter, 1997). This activation now enables PLC-gam m al to hydrolyze DAG
and PIP2, (Liao et al, 1993). It is also suggested that some parts of m em brane,
such as phosphatidic ad d and PIP3, m ay also contribute to activation (Kam at
& Carpenter, 1997). This activation mechanism can be seen in platelet-derived
grow th factor, epidermal grow th factor, fibroblast grow th factor, nerve grow th
factor, and hepatocyte grow th factor (Rhee & Bae, 1997).
Additionally, there are ways of inhibiting this activation process. One is
to rem ove agonist, which will lead to dephosphorylation and deactivation of
PLC -gam m a (K am at & C arpenter, 1997). A lso, it is suspected that PLC gam m al has an intracellular inhibitory m echanism w ithin the SH region
(K am at & C arpenter, 1997). E xact region and enzym es involved in this
inhibition process is not w ell-understood. H ow ever, abnorm al lack of PLCgam m al activity has

significant physiological application. In m am m alian

PLC-gam m al (-/ -) embryo, development and grow th fail to occur, leading to

death of the em bryo (Ji et al., 1997; K am at & C arp etn er, 1997). This
phenom enon is not seen in PLC -gam m al (+ /-) or (+ /+ ). Therefore, PLCgam m al is significant contributor in GH signaling processes.

Conclusion
In sum m ary, GH is responsible for grow th and developm ent of bones
and m uscles. To do this, GH uses signaling process involving GHR and
tyrosine kinase JAK2. Phosphorylation of GHR-JAK2 leads to opening up of
docking sites, which allow SH2 of specific proteins to bind. This scenario can
be applied to pathw ay using PLC -gam m al. A ctivation of PLC -gam m al leads
to hydrolyzation of DAG and IP3. A ctivation of DAG leads to activation of
PKC pathway while activation of IP3 leads to increase intracellular C a 2+. Both
of these factors are contributors of GH regulatory mechansim.
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